First Eagle Investment Management’s Option Care Health OPCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-231,037
Closed -$7.23M 434
2024
Q3
$7.23M Buy
231,037
+16,500
+8% +$506K 0.01% 219
2024
Q2
$5.94M Buy
214,537
+53,250
+33% +$1.59M 0.01% 242
2024
Q1
$5.41M Buy
161,287
+12,300
+8% +$398K 0.01% 260
2023
Q4
$5.02M Buy
148,987
+54,200
+57% +$1.67M 0.01% 251
2023
Q3
$3.07M Buy
94,787
+13,425
+17% +$453K 0.01% 271
2023
Q2
$2.64M Sell
81,362
-36,000
-31% -$1.09M 0.01% 271
2023
Q1
$3.73M Buy
117,362
+51,000
+77% +$1.53M 0.01% 213
2022
Q4
$2M Buy
66,362
+30,000
+83% +$931K 0.01% 264
2022
Q3
$1.14M Sell
36,362
-7,000
-16% -$224K ﹤0.01% 296
2022
Q2
$1.21M Buy
43,362
+16,736
+63% +$476K ﹤0.01% 276
2022
Q1
$760K Buy
26,626
+17,530
+193% +$440K ﹤0.01% 308
2021
Q4
$259K Buy
9,096
+6,500
+250% +$171K ﹤0.01% 329
2021
Q3
$63K Buy
2,596
+1,300
+100% +$30.2K ﹤0.01% 305
2021
Q2
$28K Buy
+1,296
New +$25K ﹤0.01% 261

Other funds holding OPCH

First Eagle Investment Management's OPCH Position: Q4 2024 in Review

First Eagle Investment Management sold out of Option Care Health (OPCH) in Q4 2024, closing a stake of 231,037 shares — an estimated $7.23M sold.

First Eagle Investment Management first reported a position in OPCH in Q2 2021 and held it in 14 quarters. The position peaked at $7.23M in Q3 2024. 344 funds tracked by Wall St. Rank hold OPCH as of Q4 2024.

  • First Eagle Investment Management reported no remaining Option Care Health position as of Q4 2024 after selling out during the quarter.
  • First Eagle Investment Management sold 231,037 Option Care Health shares in Q4 2024, an estimated $7.23M.
  • First Eagle Investment Management first reported a position in Option Care Health in Q2 2021 and held it in 14 quarters.
  • First Eagle Investment Management's Option Care Health position peaked at $7.23M in Q3 2024.
  • 344 funds tracked by Wall St. Rank held Option Care Health as of Q4 2024.

Based on First Eagle Investment Management's 13F filing for Q4 2024, filed 10 Feb 2025.